SAR442168

Sanofi, seeking control of key drug, to buy Principia for $3.7B
BioPharma Dive
Mon, 08/17/20 - 01:03 pm
Sanofi
Principia Biopharma
M&A
multiple sclerosis
MS
SAR442168
Sanofi posts data from contentious phase 2 multiple sclerosis trial
Fierce Biotech
Thu, 04/23/20 - 09:15 pm
Sanofi
clinical trials
MS
multiple sclerosis
Principia Biopharma
SAR442168
Multiple sclerosis “win” makes the Principia shorts squirm
EP Vantage
Thu, 02/6/20 - 10:51 am
Principia Biopharma
SAR442168
MS
multiple sclerosis